Skip to the rundown
GetYourBrief Product · Semaglutide
Search

Product · in the news since March 10, 2026

Semaglutide news

Semaglutide appeared in 11 news events on GetYourBrief between March 10, 2026 and September 24, 2026, on the Biotech and Healthcare desks. The latest: "GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk" (September 22, 2026).

When was Semaglutide in the news?

News events naming Semaglutide per month (one per story, however many outlets carried it). Source: GetYourBrief's record of the outlets' reports. April 2026 and May 2026: the intake of reports was interrupted, so these months undercount.

The latest news about Semaglutide

  1. Sep 22 · Biotech GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
  2. Sep 9 · Biotech Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
  3. Aug 4 · Healthcare Wave's Obesity siRNA Shows 16.5% Visceral Fat Improvement, Targeting 175M Patients 1
  4. Jun 23 · Biotech Lexaria says animal study GLP-1-A26-1 began dosing on schedule 2
  5. Jun 12 · Biotech leaderlive.co.uk: “Everything to know about the new Wegovy weight loss pill” 3
  6. Mar 25 · Healthcare argentinastar.com (Big News Network): “India floods market with low - cost versions of weight - loss drugs” 1
  7. Mar 21 · Healthcare Zydus launches semaglutide injection in reusable multi-dose pen device in India 2
  8. Mar 12 · Healthcare FDA sends letter to Novo Nordisk over potential GLP-1 side effects 3
  9. Mar 10 · Healthcare GLP-1 receptor agonists are being investigated as a treatment for addiction. 4

Which desks cover Semaglutide?

  1. Biotech 6
  2. Healthcare 5

Who appears in the news with Semaglutide?

  1. Novo Nordisk 10
  2. Eli Lilly 6
  3. Food and Drug Administration 3
  4. GLP-1 Receptor Agonists 3
  5. Wegovy 2
  6. MHRA 2

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).